Pharma Business review is using cookies

ContinueLearn More
September 19, 2018

Novo Nordisk to slash 400 jobs in R&D unit

Danish pharmaceutical firm Novo Nordisk has unveiled plans to lay off 400 jobs as part of its efforts to transform its approach on research & development (R&D).

Image: Novo Nordisk headquarters in Bagsværd, Denmark. Photo: courtesy of Jens Lindhe.